Status:

COMPLETED

VIDAS® NEPHROCLEAR Diagnostic Accuracy Study

Lead Sponsor:

BioMérieux

Conditions:

Acute Kidney Injury

Stage 2 Acute Kidney Injury

Eligibility:

All Genders

21+ years

Brief Summary

This is a multi-center sample analysis study in which urine samples previously collected from persons with Stage 2 or Stage 3 Acute Kidney Injury (AKI), will be tested in order to validate the VIDAS® ...

Detailed Description

The VIDAS® NEPHROCLEAR™ CCL14 Test is intended to be used in conjunction with clinical evaluation, in ICU patients with moderate to severe (stage 2 or 3) acute kidney injury (AKI), as an aid in the ri...

Eligibility Criteria

Inclusion

  • Males and females 21 years of age or older;
  • Receiving care in an intensive care unit;
  • Expected to remain in the ICU for at least 48 hours after enrollment;
  • Use of indwelling urinary catheter as standard care at the time of enrollment;
  • Subject must have acute kidney injury (KDIGO Stage 2 or Stage 3) at the time of sample collection;
  • Urine sample must be collected within 36 hours of meeting KDIGO Stage 2 criteria;
  • Documented informed consent provided by patient or legally authorized representative (LAR).

Exclusion

  • Prior kidney transplantation;
  • Comfort-measures-only status;
  • Already receiving dialysis (either acute or chronic) or in imminent need of dialysis at the time of enrollment;
  • Known infection with human immunodeficiency virus (HIV) or active hepatitis (acute or chronic); (NOTE: HIV or hepatitis testing need not be performed for enrollment in this study.)
  • Special populations, pregnant women, prisoners or institutionalized individuals;

Key Trial Info

Start Date :

July 17 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 28 2023

Estimated Enrollment :

477 Patients enrolled

Trial Details

Trial ID

NCT06036758

Start Date

July 17 2023

End Date

December 28 2023

Last Update

February 28 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

George Washington University

Washington D.C., District of Columbia, United States, 20052

2

University of Illinois

Chicago, Illinois, United States, 60612

VIDAS® NEPHROCLEAR Diagnostic Accuracy Study | DecenTrialz